Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Public ClinicalTrials.gov record NCT07538583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label Study of QRX003 Lotion in Participants With Netherton Syndrome
Study identification
- NCT ID
- NCT07538583
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Quoin Pharmaceuticals
- Industry
- Enrollment
- 16 participants
Conditions and interventions
Conditions
Interventions
- QRX003 Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 18, 2026
- Primary completion
- Jan 30, 2027
- Completion
- Mar 30, 2027
- Last update posted
- Apr 20, 2026
2026 – 2027
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Dermatology Clinical Research | Fremont | California | 94538 | Recruiting |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | Not yet recruiting |
| Dawes Fretzin Clinical Reseacrh Group | Indianapolis | Indiana | 46250 | Recruiting |
| Beacon Clinical Research | Quincy | Massachusetts | 02169 | Recruiting |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07538583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07538583 live on ClinicalTrials.gov.